Disease Control and Prevention on Wednesday recommended that decisions to use new meningitis B vaccines from Pfizer and GlaxoSmithKline in people aged 16 to 23 be made on an individual patient basis by physicians, the companies said, potentially paving
LONDON, June 22 (Reuters) - GlaxoSmithKline has agreed to sell two meningitis vaccines to Pfizer to satisfy antitrust concerns after its recent acquisition of vaccines business of Novartis.
British corporate investigator freed from a Chinese jail last week has accused officials there of deliberately withholding medical treatment to try to force him to confess to a role in a scandal involving drugmaker GlaxoSmithKline Plc ( GSK ).
SHANGHAI, June 17 (Reuters) - A British corporate sleuth and his American wife and business partner, both linked to a bribery scandal in China involving drugmaker GlaxoSmithKline PLC , were deported on Wednesday after their jail terms were reduced this month.
LONDON, June 17 (Reuters) - British drugmaker GlaxoSmithKline is investing $95 million to create a new U.S. research institute led by a top genomics professor to investigate how a cell's operating system works.
LONDON, June 15 (Reuters) - GlaxoSmithKline has agreed with life sciences investment firm Avalon Ventures to bankroll three more new biotech firms, bringing to six the number of start-ups formed since the partners announced a $495 million alliance two years ago.
coverage--a margin of safety for the dividend, if you will. A couple of years ago, I thought [TICKER: GSK ] GlaxoSmithKline ( GSK ) fit that bill. When I bought it, they were paying out about two thirds of their earnings at the time. So
June 11 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc 's drug mepolizumab for severe asthma in patients aged 18 and older.
June 11 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc 's drug for severe asthma in patients aged 18 and older.
SHANGHAI, June 9 (Reuters) - A British corporate investigator linked to a bribery scandal in China involving drugmaker GlaxoSmithKline PLC is to be released early from a 2 1/2-year sentence in a Chinese jail, a source close to his family said on Tuesday.